Literature DB >> 2565980

Haplotypes identified by 10 DNA restriction fragment length polymorphisms at the human low density lipoprotein receptor gene locus.

M J Kotze1, E Langenhoven, A E Retief, H C Seftel, H E Henderson, H F Weich.   

Abstract

Ten useful two allele restriction fragment length polymorphisms of the low density lipoprotein receptor gene were used for haplotype analysis in 45 unrelated familial hypercholesterolaemic (FH) patients, 60 normal controls, and 32 FH homozygotes, all of whom were white Afrikaners. Pedigree analysis in 27 informative heterozygous FH and 23 normal families has shown the segregation of at least 17 haplotypes in the normal population (111 chromosomes) compared to a predominant association of two of these haplotypes with the disease in the FH subjects. This association was further confirmed in 32 FH homozygotes, indicating at least two 'founder' members for the disease in the Afrikaner population. Recombination events were not detected in any of the families studied and we thus conclude that the haplotypes associated with FH function as specific markers for the disease and will allow presymptomatic diagnosis in affected families.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2565980      PMCID: PMC1017299          DOI: 10.1136/jmg.26.4.255

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  17 in total

1.  Prevalence of familial hypercholesterolaemia in three rural South African communities.

Authors:  P L Jooste; A J Benadé; J E Rossouw
Journal:  S Afr Med J       Date:  1986-04-26

Review 2.  A receptor-mediated pathway for cholesterol homeostasis.

Authors:  M S Brown; J L Goldstein
Journal:  Science       Date:  1986-04-04       Impact factor: 47.728

3.  A DNA polymorphism in the human low-density lipoprotein receptor gene.

Authors:  M J Kotze; A E Retief; P A Brink; H F Weich
Journal:  S Afr Med J       Date:  1986-07-19

4.  Pst I RFLP close to the LDL receptor gene.

Authors:  H Funke; J Klug; P Frossard; R Coleman; G Assmann
Journal:  Nucleic Acids Res       Date:  1986-10-10       Impact factor: 16.971

5.  The LDL receptor gene: a mosaic of exons shared with different proteins.

Authors:  T C Südhof; J L Goldstein; M S Brown; D W Russell
Journal:  Science       Date:  1985-05-17       Impact factor: 47.728

6.  A RFLP associated with the low-density lipoprotein receptor gene (LDLR).

Authors:  M J Kotze; E Langenhoven; E Dietzsch; A E Retief
Journal:  Nucleic Acids Res       Date:  1987-01-12       Impact factor: 16.971

7.  The human LDL receptor: a cysteine-rich protein with multiple Alu sequences in its mRNA.

Authors:  T Yamamoto; C G Davis; M S Brown; W J Schneider; M L Casey; J L Goldstein; D W Russell
Journal:  Cell       Date:  1984-11       Impact factor: 41.582

8.  A host of hypercholesterolaemic homozygotes in South Africa.

Authors:  H C Seftel; S G Baker; M P Sandler; M B Forman; B I Joffe; D Mendelsohn; T Jenkins; C J Mieny
Journal:  Br Med J       Date:  1980-09-06

9.  Haplotype associations of three DNA polymorphisms at the human low density lipoprotein receptor gene locus in familial hypercholesterolaemia.

Authors:  M J Kotze; E Langenhoven; A E Retief; K Steyn; M P Marais; J J Grobbelaar; C J Oosthuizen; H F Weich; A J Benadé
Journal:  J Med Genet       Date:  1987-12       Impact factor: 6.318

10.  A common DNA polymorphism of the low-density lipoprotein (LDL) receptor gene and its use in diagnosis.

Authors:  S E Humphries; A M Kessling; B Horsthemke; J A Donald; M Seed; N Jowett; M Holm; D J Galton; V Wynn; R Williamson
Journal:  Lancet       Date:  1985-05-04       Impact factor: 79.321

View more
  10 in total

Review 1.  Medical genetics in South Africa.

Authors:  T Jenkins
Journal:  J Med Genet       Date:  1990-12       Impact factor: 6.318

2.  Evidence of a long QT founder gene with varying phenotypic expression in South African families.

Authors:  T de Jager; C H Corbett; J C Badenhorst; P A Brink; V A Corfield
Journal:  J Med Genet       Date:  1996-07       Impact factor: 6.318

3.  Identification of a 76-year-old patient with compound heterozygous familial hypercholesterolemia by haplotype analysis of the LDL receptor gene.

Authors:  H J Fischer; H Schuster; C Keller; G Wolfram; N Zöllner
Journal:  Klin Wochenschr       Date:  1991-11-15

4.  Use of DNA haplotype analysis in diagnosis of familial hypercholesterolaemia in 31 German families.

Authors:  H Schuster; G Rauh; C Gerl; C Keller; G Wolfram; N Zöllner
Journal:  J Med Genet       Date:  1991-12       Impact factor: 6.318

5.  Founder effect and prevalence of myotonic dystrophy in South Africans: molecular studies.

Authors:  A Goldman; A Krause; M Ramsay; T Jenkins
Journal:  Am J Hum Genet       Date:  1996-08       Impact factor: 11.025

6.  An exon 4 mutation identified in the majority of South African familial hypercholesterolaemics.

Authors:  M J Kotze; L Warnich; E Langenhoven; L du Plessis; A E Retief
Journal:  J Med Genet       Date:  1990-05       Impact factor: 6.318

7.  RFLPs of the LDL-receptor gene: their use in the diagnosis of FH and in evaluation of different levels of gene expression on normal subjects.

Authors:  S Bertolini; D A Coviello; P Masturzo; E Zucchetto; N Elicio; R Balestreri; G Orecchini; S Calandra; S Humphries
Journal:  Eur J Epidemiol       Date:  1992-05       Impact factor: 8.082

8.  Polymorphic haplotypes and recombination rates at the LDL receptor gene locus in subjects with and without familial hypercholesterolemia who are from different populations.

Authors:  A R Miserez; H Schuster; N Chiodetti; U Keller
Journal:  Am J Hum Genet       Date:  1993-04       Impact factor: 11.025

9.  Screening for mutations in exon 4 of the LDL receptor gene: identification of a new deletion mutation.

Authors:  L Theart; M J Kotze; E Langenhoven; O Loubser; A V Peeters; C J Lintott; R S Scott
Journal:  J Med Genet       Date:  1995-05       Impact factor: 6.318

10.  Molecular genetic evidence for a founder effect in familial hypercholesterolemia among French Canadians.

Authors:  C Bétard; A M Kessling; M Roy; A Chamberland; S Lussier-Cacan; J Davignon
Journal:  Hum Genet       Date:  1992-03       Impact factor: 4.132

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.